{"transactions":[{"id":1149,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":971,"kind":"person","name":"Marschel Peter Klaus","position":1,"cik":"0002079859","reported_name":"Marschel Peter Klaus","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-09-02T21:49:41.000Z","date":"2026-08-31","kind":"grant","planned":false,"acquired":true,"shares":3900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock granted under the Decoy Therapeutics Inc. 2026 Equity Incentive Plan. 25 percent of the restricted stock vested immediately, and the remainder will vest in approximately equal monthly increments over the next 36 months."}],"balance_after":3900,"source":{"system":"sec-edgar","filing":"0002079859-26-000002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2079859/000207985926000002/ownership.xml","form_type":"4"}}]}